On June 2nd (Thursday), we welcomed Prof Margaret Sheil (President of QUT), Prof Mark Harvey (Vice-President of QUT), Mr. Takeshi Adachi (Queensland Trade Commissioner to Japan), and Ms. Annu Tamura (Senior Business Development Manager) to Hirotsu Bioscience headquarters in Tokyo.
During their visit, details of the progress that has been made on cancer-specific screening and the N-NOSE project in Japan were shared including progress on the large-scale clinical study for N-NOSE that is currently underway by QUT in Australia.

TOKYO, JAPAN – March 6, 2026 – HIROTSU Bio Science Inc. announced the establishment of a new U.S. subsidiary, Hirotsu Global Inc., effectively c . . .
2026.03.06FOR IMMEDIATE RELEASE HIROTSU Bio Science Announces Referral of Former Employee to Prosecutors for Violation of the Unfair Competition Preven . . .
2026.02.05A novel, non-invasive approach to detecting micro-distant metastasis in highly lethal pancreatic cancer. TOKYO, JAPAN – January 5, 2026 – HIR . . .
2026.01.05